Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Susanna V. Ulahannan | Researchclopedia

Back to researchers

Susanna V. Ulahannan

Oklahoma State University Oklahoma City ORCID

259

Works

3,248

Citations

25

h-index

47

i10-index

Research Topics

Cancer Immunotherapy and Biomarkers Colorectal Cancer Treatments and Studies Cancer, Hypoxia, and Metabolism

Affiliations

National Institutes of Health2013–2017

Johns Hopkins University2011–2011

Oklahoma City University2020–2025

University of Oklahoma Medical Center2023–2024

Sarah Cannon2018–2025

Top Works

Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma

Austin G. Duffy,Susanna V. Ulahannan,et al.

2016807 citations

Lung Cancer Treatments and Mutations

Peroxisome Proliferator-Activated Receptors

Population attributable fractions of risk factors for hepatocellular carcinoma in the United States

Oxana V. Makarova‐Rusher,Sean F. Altekruse,et al.

2016323 citations

The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial

Jason J. Luke,Manish R. Patel,et al.

2023116 citations

Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial

Jayesh Desai,Guzmán Alonso,et al.

2023112 citations

Earlier presentation and application of curative treatments in hepatocellular carcinoma

Susanna V. Ulahannan,Austin G. Duffy,et al.

201482 citations

Phase I and Preliminary Phase II Study of TRC105 in Combination with Sorafenib in Hepatocellular Carcinoma

Austin G. Duffy,Chi Ma,et al.

201776 citations

Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750—an antisense oligonucleotide against eIF4E—in combination with irinotecan in solid tumors and irinotecan‐refractory colorectal cancer

Austin G. Duffy,Oxana V. Makarova‐Rusher,et al.

201673 citations

A12 The SHP2 Inhibitor RMC-4630 in Patients with KRAS-Mutant Non-Small Cell Lung Cancer: Preliminary Evaluation of a First-in-Man Phase 1 Clinical Trial

Sai‐Hong Ignatius Ou,Marianna Koczywas,et al.

202073 citations

Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid Tumors

Emerson A. Lim,Johanna C. Bendell,et al.

202269 citations